Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children as directed by a healthcare professional.

GNH USA supplies Nasonex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasonex (mometasone furoate) is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.

Seasonal allergic rhinitis: relief of nasal congestion, itching, and sneezing. Perennial allergic rhinitis: control of chronic nasal symptoms. Nasal polyps: reduction of polyp size and improvement of nasal airflow.

Nasonex may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste or taste loss

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes such as cataracts or glaucoma - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal passages

Before using Nasonex, consider the following safety measures.

Pregnancy: consult a healthcare professional; safety not fully established. Breastfeeding: discuss potential risks with a physician. Pediatric use: follow pediatric dosing recommendations. Hypersensitivity: avoid if known allergy to mometasone or formulation components. Do not exceed prescribed dose: prolonged high‑dose therapy may affect adrenal function. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasonex can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may increase mometasone levels. - Ritonavir: may elevate systemic exposure. - Concurrent nasal sprays or decongestants: may cause local irritation.